- Home
- AI vs CRNX Comparison
AI vs CRNX Comparison
Compare AI & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AI
- CRNX
- Stock Information
- Founded
- AI 2009
- CRNX 2008
- Country
- AI United States
- CRNX United States
- Employees
- AI N/A
- CRNX N/A
- Industry
- AI Computer Software: Prepackaged Software
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- AI Technology
- CRNX Health Care
- Exchange
- AI Nasdaq
- CRNX Nasdaq
- Market Cap
- AI 2.3B
- CRNX 2.8B
- IPO Year
- AI 2020
- CRNX 2018
- Fundamental
- Price
- AI $17.85
- CRNX $35.84
- Analyst Decision
- AI Hold
- CRNX Strong Buy
- Analyst Count
- AI 15
- CRNX 7
- Target Price
- AI $24.62
- CRNX $74.33
- AVG Volume (30 Days)
- AI 9.6M
- CRNX 1.3M
- Earning Date
- AI 09-03-2025
- CRNX 11-11-2025
- Dividend Yield
- AI N/A
- CRNX N/A
- EPS Growth
- AI N/A
- CRNX N/A
- EPS
- AI N/A
- CRNX N/A
- Revenue
- AI $372,104,000.00
- CRNX $1,392,000.00
- Revenue This Year
- AI N/A
- CRNX $469.59
- Revenue Next Year
- AI $13.39
- CRNX $705.27
- P/E Ratio
- AI N/A
- CRNX N/A
- Revenue Growth
- AI 14.34
- CRNX 0.51
- 52 Week Low
- AI $14.70
- CRNX $24.10
- 52 Week High
- AI $45.08
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- AI 50.64
- CRNX 60.90
- Support Level
- AI $17.38
- CRNX $33.28
- Resistance Level
- AI $18.34
- CRNX $35.91
- Average True Range (ATR)
- AI 0.87
- CRNX 1.51
- MACD
- AI 0.48
- CRNX -0.06
- Stochastic Oscillator
- AI 76.54
- CRNX 60.52
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.